Amended Statement of Ownership (sc 13g/a)
January 31 2013 - 4:11PM
Edgar (US Regulatory)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
Amendment No.: 2*
Name of Issuer: PSS World Medical, Inc.
Title of Class of Securities: Common Stock
CUSIP Number: 69366A100
Date of Event Which Requires Filing of this Statement: 12/31/2012
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed.
[X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
CUSIP No.: 69366A100
1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE
PERSON Janus Capital Management LLC EIN #75-3019302
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP a. ___ b. ___ 3. SEC
USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
5. SOLE VOTING POWER 0**
6. SHARED VOTING POWER -0-
7. SOLE DISPOSITIVE POWER 0**
8. SHARED DISPOSITIVE POWER -0-
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0**
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
Not applicable
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.0%**
12. TYPE OF REPORTING PERSON IA, HC
** See Item 4 of this filing
Item 1.
(a). Name of Issuer: PSS World Medical, Inc. ("PSS World Medical")
(b). Address of Issuer's Principal Executive Offices:
4345 Southpoint Blvd. Jacksonville, FL 32216
Item 2.
(a).-(c). Name, Principal Business Address, and Citizenship of Persons
Filing:
(1) Janus Capital Management LLC ("Janus Capital") 151 Detroit Street
Denver, Colorado 80206 Citizenship: Delaware
(d). Title of Class of Securities: Common Stock
(e). CUSIP Number: 69366A100
Item 3.
This statement is filed pursuant to Rule 13d-1 (b) or 13d-2(b) and the
person filing, Janus Capital, is an investment adviser in accordance
with Section 240.13d-1(b)(ii)(E) as well as a parent holding
company/control person in accordance with Section 240.13d-1(b)(ii)(G).
See Item 4 for additional information.
Item 4. Ownership
The information in items 1 and 5 through 11 on the cover page(s) on
Schedule 13G is hereby incorporated by reference.
Janus Capital has a direct 95.67% ownership stake in INTECH Investment
Management ("INTECH") and a direct 77.8% ownership stake in Perkins
Investment Management LLC("Perkins"). Due to the above ownership
structure, holdings for Janus Capital, Perkins and INTECH are aggregated
for purposes of this filing. Janus Capital, Perkins and INTECH are
registered investment advisers, each furnishing investment advice to
various investment companies registered under Section 8 of the
Investment Company Act of 1940 and to individual and institutional
clients (collectively referred to herein as "Managed Portfolios").
As a result of its role as investment adviser or sub-adviser to the
Managed Portfolios, Janus Capital may be deemed to be the beneficial
owner of 0 shares or 0.0% of the shares outstanding of PSS World Medical
Common Stock held by such Managed Portfolios. However, Janus Capital
does not have the right to receive any dividends from, or the proceeds
from the sale of, the securities held in the Managed Portfolios and
disclaims any ownership associated with such rights.
As a result of its role as investment adviser or sub-adviser to the
Managed Portfolios, Perkins may be deemed to be the beneficial owner of
0 shares or 0.0% of the shares outstanding of PSS World Medical Common
Stock held by such Managed Portfolios. However, Perkins does not have
the right to receive any dividends from, or the proceeds from the sale
of, the securities held in the Managed Portfolios and disclaims any
ownership associated with such rights.
Item 5. Ownership of Five Percent or Less of a Class
This statement is being filed to report the fact that the reporting
persons have ceased to be the beneficial owners of more than five
percent of the class of securities.
Item 6. Ownership of More than Five Percent on Behalf of Another Person
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent Holding Company
Perkins is a direct subsidiary of Janus Capital (Janus Capital has a
direct 77.8% ownership stake) and is a registered investment adviser
furnishing investment advice to various investment companies registered
under Section 8 of the Investment Company Act of 1940 and to individual
and institutional clients.
Item 8. Identification and Classification of Members of the Group
Not applicable.
Item 9. Notice of Dissolution of Group
Not applicable.
Item 10. Certification
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have the
effect of changing or influencing the control of the issuer of such
securities and were not acquired in connection with or as a participant
in any transaction having such purposes or effect.
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true,
complete and correct.
JANUS CAPITAL MANAGEMENT LLC
By /s/ David R. Kowalski 1/31/2013 David R. Kowalski,
Date Senior Vice President and CCO
PERKINS INVESTMENT MANAGEMENT LLC
By /s/ David R. Kowalski 1/31/2013 David R. Kowalski,
Date Vice President
|
PSS World Medical (NASDAQ:PSSI)
Historical Stock Chart
From Jul 2024 to Aug 2024
PSS World Medical (NASDAQ:PSSI)
Historical Stock Chart
From Aug 2023 to Aug 2024